The chemical class of PCDHA1 inhibitors refers to a group of molecules that interact with and inhibit the activity of the protein encoded by the PCDHA1 gene, which belongs to the protocadherin alpha gene cluster, a subset of the cadherin superfamily. Protocadherins are cell adhesion molecules that are primarily expressed in the nervous system and are involved in establishing and maintaining specific cell-cell connections critical for proper neural circuitry. The function of PCDHA1, like other protocadherins, is to mediate homophilic intercellular interactions, which are interactions between identical molecules on the surfaces of adjacent cells. Inhibitors of PCDHA1 would bind to the protein in a manner that disrupts its adhesive function, preventing it from effectively mediating cell-cell adhesion. The design and identification of such inhibitors would be a complex task, requiring a deep understanding of the protein's structure, the nature of its interactions with other cell surface proteins, and the precise mechanisms by which it contributes to cell adhesion.
Identifying PCDHA1 inhibitors would typically involve high-throughput screening (HTS) to test large libraries of compounds for their ability to disrupt PCDHA1-mediated cell adhesion. This could be observed through various in vitro assays that simulate the cell-cell interactions facilitated by PCDHA1. Initial hits from these screens would be molecules that show potential in disrupting the protein-protein interactions. These leads would then be further characterized for their specificity, ensuring they do not non-selectively interfere with other members of the protocadherin family or other cell adhesion molecules. Detailed biochemical and biophysical analyses, including binding affinity studies and competition assays, would be employed to characterize the interaction between the inhibitors and PCDHA1. Additionally, structural studies, such as X-ray crystallography or cryo-electron microscopy, might be used to elucidate the precise mode of interaction at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase (HDAC) inhibitor that can alter chromatin structure, leading to a broad change in gene expression, possibly reducing PCDHA1 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound is a DNA methyltransferase inhibitor that can result in DNA demethylation, potentially affecting the expression of PCDHA1 by altering its promoter methylation status. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is another DNA methyltransferase inhibitor that could potentially demethylate the PCDHA1 promoter, thereby inhibiting its expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, or SAHA, is an HDAC inhibitor that can change gene expression patterns across many genes, which could include PCDHA1. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
This antibiotic binds to DNA and can inhibit transcription factor binding, potentially reducing expression of genes like PCDHA1. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA and can inhibit RNA polymerase, which could decrease transcription of the PCDHA1 gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine is a DNA methyltransferase inhibitor that could lead to hypomethylation and reduced expression of PCDHA1. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can modulate histone acetylation and DNA methylation, affecting gene expression profiles including potentially PCDHA1. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat is an HDAC inhibitor that can affect the expression of various genes by altering chromatin structure, potentially including PCDHA1. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Parthenolide may affect NF-κB signaling, which can have downstream effects on gene expression, possibly impacting PCDHA1. | ||||||